Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft

Genes Chromosomes and Cancer

Volumn 24, Issue 2, 1999, Pages 119-126

  Van Alewijk, Dirk C J G ^a   Van Der Weiden, Marcel M ^a   Eussen, Bert J ^a   Van Den Andel Thijssen, Lydia D ^a   Ehren Van Eekelen, Conny C ^a   König, Josée J ^a   Van Steenbrugge, Gert J ^a   Dinjens, Winand N ^a   Trapman, Jan ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CENTROMERE; CHROMOSOME 8P; CHROMOSOME DELETION; CHROMOSOME MAP; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE; XENOGRAFT; YEAST ARTIFICIAL CHROMOSOME;

ANIMALS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; GENETIC MARKERS; HOMOZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MICE, NUDE; PHYSICAL CHROMOSOME MAPPING; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032902163     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199902)24:2<119::AID-GCC4>3.0.CO;2-6     Document Type: Article

References (36)

1. Albertsen HM, Abderrahim H, Cann HM, Dausset J, Le Paslier D. 1990. Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci USA 87:4256-4260.
2. Bergerheim US, Kunimi K, Collins VP, Ekman P. 1991. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 3:215-220.
3. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiuara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB. 1993. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873.
4. Bova GS, Macgrogan D, Levy A, Pin SS, Bookstein R, Isaacs WB. 1996. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics 35:46-54.
5. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D. 1997. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997-5000.
6. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB. 1990. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
7. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. 1996. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
8. Chumakov I, Rigault P, Guillou S, Ougen P, Billaut A, Guasconi G, Gervy P, LeGall I, Soularue P, Grinas L, Bougueleret L, Bellanne-Chantelot C, Lacroix B, Barillot E, Gesnouin P, Pook S, Vaysseix G, Frelat G, Schmitz A, Sambucy J, Bosch A, Estivill X, Weissenbach J, Vignal A, Riethman H, Cox D, Patterson D, Gardiner K, Hattori M, Sakaki Y, Ichikawa H, Ohki M, Le Paslier D, Heilig R, Antonarakis S, Cohen D. 1992. Continuum of overlapping clones spanning the entire human chromosome 21q. Nature 359:380-387.
9. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154.
10. Donlon T, Wyman AR, Mulholland J, Barker D, Bruns G, Latt S, Botstein D. 1986. Alpha satellitelike sequences at the centromere of chromosome 8. Am J Hum Genet 39:196.
11. Green ED, Olson MV. 1990. Systematic screening of yeast artificial-chromosome libraries by use of the polymerase chain reaction. Proc Natl Acad Sci USA 87:1213-1217.
12. Gustafson CE, Wilson PJ, Lukeis R, Baker E, Woollatt E, Annab L, Hawke L, Barrett JC, Chenevixtrench G. 1996. Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer. Cancer Res 56:5238-5245.
13. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
14. Ichikawa T, Nihei N, Suzuki H, Oshimura M, Emi M, Nakamura Y, Hayata I, Isaacs JT, Shimazaki J. 1994. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8 Cancer Res 54:2299-2302.
15. Isaacs WB. 1995. Molecular genetics of prostate cancer. Cancer Surv 25:357-379.
16. Kagan J, Stein J, Babaian RJ, Joe YS, Pisters LL, Glassman AB, von Eschenbach AC, Troncoso P. 1995. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene 11:2121-2126.
17. Kallioniemi OP, Visakorpi T. 1996. Genetic basis and clonal evolution of human prostate cancer. Adv Cancer Res 68:225-255.
18. Kunimi K, Bergerheim US, Larsson IL, Ekman P, Collins VP. 1991. Allelotyping of human prostatic adenocarcinoma. Genomics 11:530-536.
19. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
20. Macgrogan D, Levy A, Bova GS, Isaacs WB, Bookstein R. 1996. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics 35:55-65.
21. NIH/CEPH Collaborative Mapping Group. 1992. A comprehensive genetic linkage map of the human genome. Science 258:67-86.
22. Nihei N, Ichikawa T, Kawana Y, Kuramochi H, Kugoh H, Oshimura M, Hayata I, Shimazaki J, Ito H. 1996. Mapping of metastasis suppressor gene(s) for rat prostate cancer on the short arm of human chromosome 8 by irradiated microcell-mediated chromosome transfer. Genes Chromosomes Cancer 17:260-268.
23. Parker SL, Tong T, Bolden S, Wingo PA. 1997. Cancer statistics, 1997. CA Cancer J Clin 47:5-27.
24. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
25. Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E, Weinstein CL, Bittner M, Meltzer PS, Trent JM, Yeo CJ, Hruban RH, Kern SE. 1995. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA 92:5950-5954.
26. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 15:356-362.
27. Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Konishi M, Oshimura M, Miyaki M. 1996. Suppression of tumorigenicity and invasiveness of colon carcinoma cells by introduction of normal chromosome 8p12-pter. Oncogene 12:405-410.
28. Trapman J, Sleddens H, Vanderweiden MM, Dinjens W, Konig JJ, Schroder FH, Faber PW, Bosman, FT. 1994. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:6061-6064.
29. van Weerden WM, de Ridder CM, Verdaasdonk CL, Romijn JC, van der Kwast TH, Schroder FH, van Steenbrugge GJ. 1996. Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 149:1055-1062.
30. Vlietstra RJ, van Alewijk DC, Hermans KG, van Steenbrugge GJ, Trapman J. 1998. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res 58:2720-2723.
31. Weber B, Riess O, Kreklywich CN, Wood S, Hayden, MR. 1991. A polymorphic DNA marker at the D8S131 locus. Nucleic Acids Res 19:17-25.
32. Wood S, Schertzer M. 1992. Linkage mapping of the D8S133 locus to chromosome 8p using a highly informative, polymorphic, complex dinucleotide repeat. Genomics 13:232.
33. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
34. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD. 1996a. Positional cloning of the Werner's syndrome gene. Science 272:258-262.
35. Yu CE, Oshima J, Hisama FM, Matthews S, Trask BJ, Schellenberg GD. 1996b. A YAC, P1, and cosmid contig and 17 new polymorphic markers for the Werner syndrome region at 8p12-p21. Genomics 35:431-440.
36. Yu CE, Oshima J, Wijsman EM, Nakura J, Miki T, Piussan C, Matthews S, Fu YH, Mulligan J, Martin GM, Schellenberg GD. 1997. Mutations in the consensus helicase domains of the Werner syndrome gene. Am J Hum Genet 60:330-341.